Cure has partnered with the Biotechnology Institute to support its mission to engage, excite and educate students about biotechnology's immense potential in healthcare, the economy, and environmental balance. On October 28 to 30, 2024, during the BioFuture Conference, Cure will host the Institute's "flagship" program, the BioGENEius Challenge.

The BioGENEius Challenge provides high school age students with expanded opportunities to compete and be recognized for outstanding research in biotechnology. By promoting excellence in research from the best and brightest minds in the next generation of innovators, the program promotes workforce development and training to sustain the industry's growth and impact. Cure looks forward to showcasing the program's top finalists, drawn from state and regional science competitions across the United States.

Cure has partnered with the Clinton Global Initiative to collaboratively pursue endeavors that address global health issues of equity, artificial intelligence, climate and maternal health, at venues ranging from New York City to COP28. The partnership has presented many opportunities to jointly foster collaborative innovations and actions that leverage science, technology and policy across disciplines, sectors and geographies.

Cure has partnered with Evvy, an innovative company unlocking precision women’s healthcare through novel, overlooked female biomarkers — starting with the vaginal microbiome, to host a program with leaders across healthcare, policy, tech and media to address the gender health gap and highlight the significance of Equal Research Day, June 10, 2024.

Cure, in partnership with Life Science Cares New York and Science In the City Inc., with sponsorship from New York Economic Development Corporation, launched Science Day as an immersive educational program for New York City high school students interested in life sciences and biotechnology. The program brought 50 students to the Cure campus to learn from scientists and business leaders through an educational panel and interactive workshop session.

Cure and the New York Academy of Sciences have partnered on an exciting series of programs to explore how startups are leveraging AI technology for the science and business of drug discovery and development. Our events gather renowned experts from industry, academia, and research centers to gain insight on the ways AI can bring speed, precision and accuracy to identifying new therapies.

Cure and Scientific American (SciAm), one of the most trusted and authoritative sources for news and information about science, health, technology, the environment and society, are co-hosting an event series on FutureHealth to distill the clearest stories of our innovation future and the global impact new research has on our collective lives.

The FutureHealth series will feature three topics:

• Breakthroughs: A primer of dazzling new technologies, procedures, and discoveries

• Holistic Health and Wellness: Reframing medicine to think holistically and in terms of integrated systems, including phenomics and the use of AI

• Reimagining Healthcare: Reforming how we deliver treatments through smart policy and using smart tech—includes issues of access, equity, and an emphasis on patients and outcomes

Cure will host the 2024 Science Summit United Nations General Assembly (SSUNGA) and bring together thought leaders, scientists, technologists, innovators, policymakers, financiers, philanthropists and community leaders and journalists to increase collaborations across a broad spectrum of themes including health, nutrition, agriculture, the environment and climate. This week-long program focuses on how science and innovation contribute to the UN Sustainable Development Goals. Visit https://sciencesummitunga.com/ for more information